BULERIA. Repositorio Institucional de la Universidad de León
Publicación
Artículo científico (JournalArticle)
Human Bone Marrow Stromal Cells Differentiate into Corneal Tissue and Prevent Ocular Graft-Versus-Host Disease in Mice
[EN] Clinical trials have assessed the use of human bone marrow stromal cells (hBMSCs) for the treatment of immune-related disorders such as graft-versus-host disease (GVHD). In the current study, we show that GFP+-transduced hBMSCs generated from bone marrow migrate and differentiate into corneal tissue after subconjunctival injection in mice. Interestingly, these hBMSCs display morphological features of epithelial, stromal, and endothelial cells and appear at different layers and with different morphologies epending on their position within the epithelium. Furthermore, these cells display ultrastructural properties, such as bundles of intermediate filaments, interdigitations, and desmosomes with GFP− cells, which confirms their differentiation into corneal tissues. GFP+-transduced hBMSCs were injected at different time points into the right eye of lethally irradiated mice undergoing bone marrow transplantation, which developed ocular GVHD (oGVHD). Remarkably, hBMSCs massively migrate to corneal tissues after subconjunctival injection. Both macroscopic and histopathological examination showed minimal or no evidence of GVHD in the right eye, while the left eye, where no hBMSCs were injected, displayed features of GVHD. Thus, in the current study, we confirm that hBMSCs may induce their therapeutic effect at least in part by differentiation and regeneration of damaged tissues in the host. Our results provide experimental evidence that hBMSCs represent a potential cellular therapy to attenuate oGVHD, SI, The authors would like to thank Didier Trono for pWPI vector plasmid. Teresa Caballero was supported by a Rio Hortega grant (code: CM10/00161) from Instituto de Salud Carlos III. We thank R. Sánchez and M. T. Sánchez for their technical assistance. We would like to thank Dr. Anton Martens, from the University Medical Center Utrecht, for providing the vectors for GFP assays. This study was partially supported by grants from FIS (PI11/02366 and PI12/00939) and Junta de Castilla y León (GR 183). The authors declare no conflicts of interest
Proyecto:
MICINN / Acción Estratégica de Salud CM10
,
MICINN / Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia PI11
,
MINECO / Acción Estratégica de Salud PI12
,
Junta de Castilla y León / Programa Nacional de Fortalecimiento Institucional GR 183